Early Toxicity and Efficacy of Four Different Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Patients With Lymphoma: Impact of Drug Shortages in a Resource-Constrained Country
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:2666-6367
-
Container-title:Transplantation and Cellular Therapy
-
language:en
-
Short-container-title:Transplantation and Cellular Therapy
Author:
Carranza JhonnyORCID,
Fatobene GiancarloORCID,
Otuyama Leonardo Jun,
dos Santos Joaquim GaspariniORCID,
Cordeiro Ana Costa,
Mariano Livia,
Rocha Vanderson
Reference30 articles.
1. Efficacy of pharmacokinetics-directed busulfan, cyclophosphamide, and etoposide conditioning and autologous stem cell transplantation for lymphoma: comparison of a multicenter phase II study and CIBMTR outcomes;Flowers;Biol Blood Marrow Transplant,2016
2. BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients;Visani;Blood,2011
3. CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?;Westin;Blood,2022
4. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomised trial;Linch;The Lancet,1993
5. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995